AzTrials
AzTrials

Infantile DiarrheaNCT02870491

Working With Community Health Workers to Increase ORS Use in Uganda

A study testing Free Distribution and Preemptive Delivery in people with Infantile Diarrhea and Diarrhea, run by University of California, Berkeley.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to assess how free distribution and preemptive home delivery of oral rehydration salts (ORS) by community health workers affects ORS use. The investigators will measure the impact of the combination of the two interventions (free distribution + pre-emptive home delivery) as well as the… Read more about this study

Who is it for?
Ages Up to 59 monthsHealthy volunteers can take part
Conditions the study is for
Infantile Diarrhea, Diarrhea, Dehydration
What is being tested?
Free Distribution and Preemptive Delivery
Could I receive a placebo?
No, everyone receives an active treatment
How many people
7,949 participants
Where
No sites listed yet
Study dates
Aug 2016to Jan 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 59 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Children aged 0-59 months that reside on a village recruited to participate in the study will be included in the intervention. Only children with a diarrhea episode 4-weeks prior to data collection will be included in the analysis.

Who cannot join

  • Children without a diarrhea episode in the weeks prior to data collection will be excluded from the analysis.

About this study

Official title: Working With Community Health Workers to Increase Oral Rehydration Salt and Zinc Use to Treat Child Diarrhea in Uganda: A Cluster Randomized Controlled Trial

The purpose of this study is to assess how free distribution and preemptive home delivery of oral rehydration salts (ORS) by community health workers affects ORS use. The investigators will measure the impact of the combination of the two interventions (free distribution + pre-emptive home delivery) as well as the impact of each intervention separately (free distribution without home delivery and pre-emptive home delivery without free distribution).

Read the detailed description

This research aims to test the impact of a novel preemptive home-delivery intervention aimed at increasing the use of oral rehydration salts (ORS) and zinc for child diarrhea in Uganda. The intervention aims to increase availability of ORS and zinc and reduce barriers to access by having community health workers (CHWs) deliver the products directly to households for free prior to a diarrhea episode. Under this set-up, the products will be readily available for free immediately after a child comes down with diarrhea. Moreover, the investigators will disentangle the mechanisms through which the intervention could change product use by using a multi-armed approach that tests for the impact of free distribution and preemptive home-delivery separately (i.e. preemptive delivery but not free and free but not preemptive delivery). The investigators will use a four-arm cluster randomized controlled trial designed to measure the impact of each of the three interventions on ORS and zinc use for treating child diarrhea relative to a control group. The investigators will enroll 120 CHWs (each located in a different village) and randomly assign each to 1 of 4 groups:

Group 1 - Control: No intervention will take place. Caretakers will have standard access to ORS and zinc at local health facilities and pharmacies. Some CHWs in control villages could make household visits, however offers to sell diarrhea treatment preemptively are rare and CHWs are generally not the source of diarrhea treatment.

Group 2 - Household Visit + Free Distribution + Preemptive Delivery: CHWs will be provided a small incentive to visit all of the households in their catchment area that contain a child under 5-years-old (roughly 100 households) at the beginning of the study. CHWs will train caretakers on the dangers of diarrhea and the importance of ORS and zinc use. CHWs will then offer to give ORS and zinc to caretakers for free to store in their homes.

Group 3 - Household Visit + Cost Sharing + Preemptive Delivery: CHWs will be provided a small incentive to visit all of the households in their catchment area that contain a child under 5-years-old at the beginning of the study. CHWs will train caretakers on the dangers of diarrhea and the importance of ORS and zinc use. CHWs will then offer to sell ORS and zinc to caretakers at their standard subsidized price (roughly USD$0.40 in total per treatment course) to store in their homes.

Group 4 - Household Visit + Free Distribution Upon Retrieval: CHWs will be provided a small incentive to visit all of the households in their catchment area that contain a child under 5-years-old at the beginning of the study. CHWs will train caretakers on the dangers of diarrhea and the importance of ORS and zinc use. CHWs will then inform caretakers that they have ORS and zinc available for free that caretakers can retrieved from the CHWs home if needed. The average distance to the CHWs household is about 15 minutes.

Groups 2-4 compared to Group 1 measures the impact of each of the different ways of arranging the program. Group 3 compared to Group 2 measures the price effect. Group 4 compared to Group 2 measures the distance/convenience effect. Group 2 compared to Group 1 measures the combination of the price and distance/convenience effect.

Being tested
Free Distribution, Preemptive Delivery
Keywords
Child Diarrhea, Cluster Randomized Controlled Trial, Oral Rehydration, ORS, Zinc, Brac, Community Health Workers, Uganda
Medical subject headings
Diarrhea, Infantile, Diarrhea, Dehydration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Free DistributionBehavioural

    Caretakers of children under 5-years-old will have access to free ORS and zinc

  • Preemptive DeliveryBehavioural

    Caretakers of children under 5-years-old will have ORS and zinc delivered to their home

Study groups in NCT02870491
Study groupRoleWhat they receive
ControlNo interventionExisting standard of care.
Free Distribute+Preemptive DeliveryExperimentalCommunity health workers (CHWs) will deliver oral rehydration salts (ORS) and zinc for free to all households in their catchment area with a child under 5-years-old at the beginning of the study.
Receives: Behavioral: Free Distribution; Behavioral: Preemptive Delivery
Cost Sharing + Preemptive DeliveryExperimentalCHWs will visit all households with a child under 5-years-old at the beginning of the study and offer to sell ORS and zinc to caretakers at the time of the visit for them to store in their homes.
Receives: Behavioral: Preemptive Delivery
Free Distribution Upon RetrievalExperimentalCHWs will visit all households with a child under 5-years-old at the beginning of the study and inform caretakers that they have ORS and zinc available for free that caretakers can retrieved from the CHWs home if needed.
Receives: Behavioral: Free Distribution

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oral rehydration salt (ORS) use

    Caretaker-reported ORS use to treat a diarrhea episode in the last 4 weeks

    Measured: Last 4 weeks

Secondary outcomes (4)
  1. Oral rehydration salt (ORS) with Zinc use

    Caretaker-reported ORS + zinc use to treat a diarrhea episode in the last 4 weeks

    Measured: Last 4 weeks

  2. Antibiotic use

    Caretaker-reported antibiotic use to treat a diarrhea episode in the last 4 weeks

    Measured: Last 4 weeks

  3. Time to Oral rehydration salt (ORS) use

    Caretaker-reported time from diarrhea initiation to ORS use

    Measured: Last 4 weeks

  4. Time to zinc use

    Caretaker-reported time from diarrhea initiation to zinc use

    Measured: Last 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Aug 2016 (estimated)
  2. Study startAug 2016
  3. Primary completionJun 2017
  4. Study completionJan 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Factorial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
7,949 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02870491
Sponsor's protocol ID
ZW-03-28-1983
Status last verified
Apr 2019
First submitted
9 Aug 2016
Last updated
8 Apr 2019
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes: Data will be made available to the public after the results are published

Questions about this trial

What is this clinical trial studying?

A study testing Free Distribution and Preemptive Delivery in people with Infantile Diarrhea and Diarrhea, run by University of California, Berkeley.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oral rehydration salt (ORS) use (time frame: Last 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in